Last Updated on October 15, 2024 by The Health Master
Leading homegrown drug makers Aurobindo Pharma and Sun Pharmaceutical Industries are recalling different products in the US market due to deviation from standard manufacturing norms.
Aurobindo Pharma
According to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of Aurobindo Pharma is recalling 1,15,776 bottles of Moxifloxacin Ophthalmic Solution, an antibiotic used in the treatment of bacterial infections.
According to the USFDA, the Princeton-based Aurobindo Pharma USA Inc is recalling the affected lot due to “failed impurities/degradation specifications”.
The company initiated the nationwide Class II recall on January 14 this year.
Sun Pharma
The USFDA said the US-based arm of Sun Pharma is recalling 59,232 bottles of Chlorthalidone tablets, which are used for reducing excess fluid levels in the body.
As per the US health regulator, the New Jersey-based Sun Pharma Inc is recalling the affected lot due to “foreign matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup”.
The company initiated the Class II voluntary recall on February 7, 2022.
As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
According to industry estimates, the US generic drug market was estimated to be around USD 115.2 billion in 2019.
Drug recall: Medical Device – Infusion Pumps recalled due to this reason
Drug recall: Red Mammoth capsules recalled due to this reason
Drug recall: Red Pill Capsules recalled due to this reason
Drug recall: Blaine Labs recalled of RevitaDerm Wound Care Gel Due to this reason
Drug recall: Mylan Pharma recalled Insulin Glargine inj due to this reason
Drug recall: Sun Pharma, Lupin recall these drugs
Drug recall: Medical Device – Infusion Pumps recalled due to this reason
How Antibiotics polluting Indian rivers: Study
Now, focus on e-consultation: Govt
Clinical trial of plant based drug for fatty liver soon: CDRI
DCGI announces classification for 133 Medical Devices in general hospital and…
USFDA gives nod to Zydus to market Dapagliflozin tablets
CDSCO gives nod to Cipla to conduct study on Paxlovid
IPA to organise 7th Global Pharmaceutical Quality Summit
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
